- Home
- OPTN vs DOMH Comparison
OPTN vs DOMH Comparison
Compare OPTN & DOMH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OPTN
- DOMH
- Stock Information
- Founded
- OPTN 2010
- DOMH 1967
- Country
- OPTN United States
- DOMH United States
- Employees
- OPTN N/A
- DOMH N/A
- Industry
- OPTN Biotechnology: Pharmaceutical Preparations
- DOMH Biotechnology: Pharmaceutical Preparations
- Sector
- OPTN Health Care
- DOMH Health Care
- Exchange
- OPTN Nasdaq
- DOMH Nasdaq
- Market Cap
- OPTN 55.4M
- DOMH 48.5M
- IPO Year
- OPTN 2017
- DOMH N/A
- Fundamental
- Price
- OPTN $9.17
- DOMH $3.99
- Analyst Decision
- OPTN Hold
- DOMH
- Analyst Count
- OPTN 3
- DOMH 0
- Target Price
- OPTN $9.00
- DOMH N/A
- AVG Volume (30 Days)
- OPTN 141.6K
- DOMH 723.9K
- Earning Date
- OPTN 05-13-2025
- DOMH 04-15-2025
- Dividend Yield
- OPTN N/A
- DOMH 8.02%
- EPS Growth
- OPTN N/A
- DOMH N/A
- EPS
- OPTN N/A
- DOMH N/A
- Revenue
- OPTN $78,226,000.00
- DOMH $18,146,000.00
- Revenue This Year
- OPTN $30.49
- DOMH N/A
- Revenue Next Year
- OPTN $13.51
- DOMH N/A
- P/E Ratio
- OPTN N/A
- DOMH N/A
- Revenue Growth
- OPTN 10.20
- DOMH 789.95
- 52 Week Low
- OPTN $4.82
- DOMH $0.83
- 52 Week High
- OPTN $20.03
- DOMH $13.58
- Technical
- Relative Strength Index (RSI)
- OPTN 76.77
- DOMH 45.02
- Support Level
- OPTN $8.75
- DOMH $3.70
- Resistance Level
- OPTN $9.28
- DOMH $4.30
- Average True Range (ATR)
- OPTN 0.14
- DOMH 0.52
- MACD
- OPTN -0.11
- DOMH 0.08
- Stochastic Oscillator
- OPTN 79.25
- DOMH 39.51
About OPTN OptiNose Inc.
OptiNose Inc is a specialty pharmaceutical company focuses on the development and commercialization of products for patients treated by ear, nose, and throat (ENT), and allergy specialists. Its first commercial product, XHANCE (fluticasone propionate) nasal spray, 93 microgram (mcg), is a therapeutic utilizing the proprietary Exhalation Delivery System (EDS) that delivers a topically-acting corticosteroid for the treatment of chronic rhinosinusitis with and without nasal polyps.
About DOMH Dominari Holdings Inc.
Dominari Holdings Inc is a biotechnology company with a diverse portfolio of small-molecule anticancer and antiviral therapeutics in development. The company's oncology therapeutics include treatments for pancreatic cancer, acute myeloid leukemia, and acute lymphoblastic leukemia.